e-learning
resources
Vienna 2012
Monday, 03.09.2012
Treatment of asthma, bronchiectasis and cough: inhaler use
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The effects of different inhaler devices on asthma control in patients with persistent asthma in Turkey
F. Yildiz, S. Akcali, N. Dursunoglu (Izmit/Kocaeli, Ankara, Denizli, Turkey)
Source:
Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Session:
Treatment of asthma, bronchiectasis and cough: inhaler use
Session type:
Thematic Poster Session
Number:
2178
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Yildiz, S. Akcali, N. Dursunoglu (Izmit/Kocaeli, Ankara, Denizli, Turkey). The effects of different inhaler devices on asthma control in patients with persistent asthma in Turkey. Eur Respir J 2012; 40: Suppl. 56, 2178
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
The effect of inhaler switching on asthma and COPD patients
Source: International Congress 2018 – Respiratory epidemiology: from COPD to factors that associate with lung function and infections
Year: 2018
Differences in inhaler misuse between patients with asthma and COPD.
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018
Improved asthma control with budesonide/formoterol
via
a single inhaler, compared with budesonide alone, in moderate persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 48s
Year: 2001
The asthmatic patient and inhaler treatment devices profile in Turkey: Asthma inhaler treatment study
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012
Budesonide/formoterol for maintenance and relief in adolescents with asthma: fewer exacerbations and improved asthma control
Source: Eur Respir J 2004; 24: Suppl. 48, 164s
Year: 2004
Preferences for current inhaler devices in patients with asthma
Source: International Congress 2018 – Asthma and drugs
Year: 2018
The economic impact recurrent inhaler versus single instructions in asthma and COPD patients
Source: Virtual Congress 2021 – Difficult decisions on expected outcomes: availability of hospital resources and improvement of treatment adherence
Year: 2021
Comparison of inhaler device preference of the physicians in the treatment of newly diagnosed adult asthma and COPD patients
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
Control of persistent asthma patients on inhaled corticosteroids in a real-life setting
Source: Annual Congress 2010 - New insights in the epidemiology of asthma
Year: 2010
Hair analysis to detect chronic inhaler drug use in asthma or COPD patients
Source: International Congress 2017 – Monitoring novel biomarkers in asthma
Year: 2017
The Anglo-French real-life experience of maintenance OCS use in omalizumab-treated patients with severe persistent allergic asthma
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008
Investigating inhaler technique in patients with COPD using different aids
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019
Improved and maintained asthma control with once-daily budesonide/formoterol single inhaler therapy in mild-to-moderate persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 21s
Year: 2001
Importance of inhaler device use status in the control of asthma and COPD: a real life study.
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018
To assess the effects of combined nasal and inhaled corticosteroid in patients with asthma and persistent allergic rhinitis
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009
A digital inhaler uncovering patterns of SABA use in asthma and COPD
Source: Virtual Congress 2020 – Digital health interventions in respiratory medicine
Year: 2020
Description of the UK’s asthma and COPD inhaler use
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
Influence of treatment by single combined inhaler on adherence of patients with asthma
Source: Annual Congress 2009 - Respiratory physiology
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept